PJC
RGEN icon

Phillip James Consulting’s Repligen RGEN Stock Holding History

Phillip James Consulting’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$1K – 369
2026
Q1 		$1K Buy
+4
New +$559 ﹤0.01% 335

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Phillip James Consulting's RGEN Position: Q2 2026 in Review

Phillip James Consulting sold out of Repligen (RGEN) in Q2 2026, closing a stake of 4 shares — an estimated $1K sold.

Phillip James Consulting first reported a position in RGEN in Q1 2026 and held it in 1 quarter. The position peaked at $1K in Q1 2026. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Phillip James Consulting reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Phillip James Consulting sold 4 Repligen shares in Q2 2026, an estimated $1K.
  • Phillip James Consulting first reported a position in Repligen in Q1 2026 and held it in 1 quarter.
  • Phillip James Consulting's Repligen position peaked at $1K in Q1 2026.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.